De Novo AL Amyloidosis in Renal Allograft and Anti-CD38 Monoclonal Antibody Treatment

Código QR

De Novo AL Amyloidosis in Renal Allograft and Anti-CD38 Monoclonal Antibody Treatment

Guardado en:

Detalles Bibliográficos
Autores principales:	Despina Fotiou, Chrysanthi Skalioti, George Liapis, Smaragdi Marinaki, Efstathios Kastritis
Formato:	article
Lenguaje:	EN
Publicado:	Wolters Kluwer 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/cea1749e955247648939f95baf5fe809
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis
por: Foteini Theodorakakou, et al.
Publicado: (2021)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
por: Zhang CL, et al.
Publicado: (2012)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
por: Lim EL, et al.
Publicado: (2013)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
por: Bodiford A, et al.
Publicado: (2015)

The expanding role of bendamustine in chronic lymphocytic leukemia
por: Nair KS, et al.
Publicado: (2015)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Raffaella Pasquale, et al.
Publicado: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
por: Monarch Shah, et al.
Publicado: (2021)

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
por: Jennifer Gill, et al.
Publicado: (2020)

All bleeding matters … but the details may not
por: Sarah H. O’Brien
Publicado: (2020)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
por: Eko A. Pangarsa, et al.
Publicado: (2021)

PP Transcon 2020 Abstracts Compilation
Publicado: (2021)

Positive/external control of rapid diagnostic tests: A step forward in malaria screening
por: Rasika D Setia, et al.
Publicado: (2021)

A rare case of mistaken identity - Historical blood group saved the situation
por: Anand Deshpande, et al.
Publicado: (2021)

Oration - Dr Sanmukh Joshi
Publicado: (2021)

OP Transcon 2020 Abstracts Compilation
Publicado: (2021)

TRANSCON 2020 45th Annual Conference ISBTI 27th & 28th Feb 2021
Publicado: (2021)

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors
por: Vijeta Bajpai, et al.
Publicado: (2021)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
por: Shoumariyeh K, et al.
Publicado: (2014)

MYC as therapeutic target in leukemia and lymphoma
por: Cortiguera MG, et al.
Publicado: (2015)

Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
por: Gupta VA, et al.
Publicado: (2013)

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources
por: Moormann AM, et al.
Publicado: (2014)

Peripheral T cell lymphoma: clinical utility of romidepsin
por: Sawey K, et al.
Publicado: (2012)

The evaluation and optimal use of rituximab in lymphoid malignancies
por: Smolewski P, et al.
Publicado: (2012)

Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
por: Samuel sarmiento Doncel, et al.
Publicado: (2021)

Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
por: Brian Eyden, et al.
Publicado: (2021)

Regulation of megakaryopoiesis by bone marrow macrophage polarization
por: Ming Hou
Publicado: (2021)

The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia
por: Hooriyeh Shapoorian, et al.
Publicado: (2021)

Immune targeted therapy for diffuse large B cell lymphoma
por: Yaxin Zheng, et al.
Publicado: (2021)

Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity
por: Shanshan Zhang, et al.
Publicado: (2021)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
por: Meletios A. Dimopoulos, et al.
Publicado: (2021)

Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients
por: Natalia Estrada, et al.
Publicado: (2021)

Summary of Joint European Hematology Association (EHA) and EuroBloodNet Recommendations on Diagnosis and Treatment of Methemoglobinemia
por: Achille Iolascon, et al.
Publicado: (2021)

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
por: Julio Delgado, et al.
Publicado: (2021)

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
por: Hans C. Hasselbalch, et al.
Publicado: (2021)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Natali Pflug, et al.
Publicado: (2021)

Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
por: Colin Vercueil, et al.
Publicado: (2021)

Azacytidine Treatment for VEXAS Syndrome
por: Marc H. G. P. Raaijmakers, et al.
Publicado: (2021)

tiRNA Join Hematopoietic Niches
por: Melania Tesio
Publicado: (2021)

Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience
por: Anne Sophie Alary, et al.
Publicado: (2021)

The EHA Research Roadmap: Normal Hematopoiesis
por: Thierry Jaffredo, et al.
Publicado: (2021)